Venture capital fund
Every published round Ziff Capital Partners took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
Companies Ziff Capital Partners has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| No portfolio companies recorded yet. | ||||
Fund closes reported for Ziff Capital Partners, as distinct from the investments it has made.
Companies Ziff Capital Partners has backed that another company then bought. An exit for the holding, not a deal Ziff Capital Partners did.
| Name | Role | Sources |
|---|---|---|
| Dr Steven M. Altschuler | Managing Director | Brandon Capital portfolio, Brandon BioCatalyst portfolio |
Stories naming Ziff Capital Partners. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Eye-disease drug developer Azura Ophthalmics has appointed healthcare biotech veteran Steven Altschuler, a Ziff Capital Partners managing director and Spark Therapeutics co-founder, as chair of its board.